eClinical Tech News

Opus Genetics announced positive Phase 3 results for its Phentolamine Ophthalmic Solution 0.75% in patients with dim light disturbances,...

Clearmind Medicine Inc. (Nasdaq: CMND) has shipped its novel psychedelic-derived drug candidate, CMND-100, to the United States for its...

Silexion Therapeutics has developed an expanded plan for SIL204, its next-generation siRNA candidate targeting KRAS-driven cancers. The company will...

Nanobiotix announced two poster presentations at the 2025 European Lung Cancer Conference showcasing Phase 1 study data for JNJ-1900...

Dyadic International received a $4.5 million grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to explore using their...

Medera Inc., a clinical-stage biopharmaceutical company, announced positive results from the Phase 1b portion of its MUSIC-HFrEF trial, evaluating...

Milestone Pharmaceuticals announced a poster presentation at the American College of Cardiology annual meeting (ACC25) from March 29th-31st, 2025,...

Creative Medical Technology Holdings (CELZ) announced positive interim data from its Phase 1/2 trial of StemSpine using AlloStem (CELZ-201-DDT),...

Genenta Science secured €20 million (approximately $21.9 million) in financing from ENEA Tech and Biomedical (ETB) to support the...

HUTCHMED announced new data from studies of savolitinib and surufatinib, two compounds it discovered, will be presented at the...